{"id":7203,"date":"2024-05-15T15:45:00","date_gmt":"2024-05-15T13:45:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/"},"modified":"2024-05-15T15:45:00","modified_gmt":"2024-05-15T13:45:00","slug":"kommunike-fran-arsstamma-i-nanexa-ab","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/","title":{"rendered":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB"},"content":{"rendered":"
\n

Den 15 maj 2024 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.<\/strong><\/p>\n<\/div>\n

\n

Resultat- och balansr\u00e4kning godk\u00e4ndes tillsammans med styrelsens f\u00f6rslag till disposition av bolagets resultat. Styrelsen och VD beviljades ansvarsfrihet f\u00f6r r\u00e4kenskaps\u00e5ret 2023.<\/p>\n

Till styrelseledam\u00f6ter omvaldes G\u00f6ran Ando, Richard Davis, Jakob Dynnes Hansen, Eva Nilsag\u00e5rd och Birgit Stattin Norinder samt nyval av Hanna Tilus. G\u00f6ran Ando omvaldes till styrelseordf\u00f6rande.<\/p>\n

St\u00e4mman beslutade om arvoden till styrelsen i enlighet med valberedningens f\u00f6rslag enligt f\u00f6ljande:
Styrelsens ordf\u00f6rande erh\u00e5ller ett arvode om 260 000 kronor och \u00f6vriga ledam\u00f6ter, som inte \u00e4r anst\u00e4llda av bolaget, erh\u00e5ller ett arvode om 130 000 kronor. Vidare utg\u00e5r ett arvode till revisionsutskottets ordf\u00f6rande om 100 000 kronor och till \u00f6vriga ledam\u00f6ter i revisionsutskottet ett arvode om 50 000 kronor.<\/p>\n

Till revisor uts\u00e5gs \u00d6hrlings PricewaterhouseCoopers AB. Niclas Bergenmo kommer att forts\u00e4tta i rollen som huvudansvarig revisor.<\/p>\n

Valberedningens f\u00f6rslag till beslut om inr\u00e4ttande av valberedning och valberedningsinstruktion godk\u00e4ndes.<\/p>\n

Enligt styrelsens f\u00f6rslag beslutade st\u00e4mman om \u00e4ndrad lydelse av bolagsordningens best\u00e4mmelser r\u00f6rande gr\u00e4nserna f\u00f6r bolagets aktiekapital och antal aktier.<\/p>\n

St\u00e4mman beslutade \u00e4ven att anta styrelsens f\u00f6rslag om bemyndiganden f\u00f6r styrelsen att besluta om f\u00f6retr\u00e4desemission samt riktad emission.<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Bolagets Certified Adviser \u00e4r Carnegie Investment Bank AB (publ).<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar injicerbara l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland Novo Nordisk och AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Den 15 maj 2024 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.<\/p>\n","protected":false},"template":"","class_list":["post-7203","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-ci-gm_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-gm-info_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nKommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Den 15 maj 2024 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab\\\/\",\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2024-05-15T13:45:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/kommunike-fran-arsstamma-i-nanexa-ab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/","og_locale":"sv_SE","og_type":"article","og_title":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB","og_description":"Den 15 maj 2024 h\u00f6lls \u00e5rsst\u00e4mma i Nanexa AB (publ), varvid st\u00e4mman beslutade i enlighet med framlagda f\u00f6rslag. De fullst\u00e4ndiga beslutsf\u00f6rslagen framg\u00e5r av kallelsen till st\u00e4mman.","og_url":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/","url":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/","name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2024-05-15T13:45:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/kommunike-fran-arsstamma-i-nanexa-ab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma i Nanexa AB"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/7203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=7203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}